Expanding Understanding of Thyroid Eye Disease Manifestations to Include Hispanic and Black Patients.

IF 0.5 Q4 OPHTHALMOLOGY
Middle East African Journal of Ophthalmology Pub Date : 2023-11-21 eCollection Date: 2022-10-01 DOI:10.4103/meajo.meajo_87_23
Tova Goldstein, Marilyn Mostowy, Jennifer Tingley, Gabriel Rand, Jee-Young Moon, Anne Barmettler
{"title":"Expanding Understanding of Thyroid Eye Disease Manifestations to Include Hispanic and Black Patients.","authors":"Tova Goldstein, Marilyn Mostowy, Jennifer Tingley, Gabriel Rand, Jee-Young Moon, Anne Barmettler","doi":"10.4103/meajo.meajo_87_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Knowledge of thyroid eye disease (TED) is based on predominantly Caucasian populations. To date, no studies in the United States examine the presentation in Black and Hispanic patients. The purpose of this study is to introduce the presentation of TED in two previously undescribed populations.</p><p><strong>Methods: </strong>This is a retrospective, cross-sectional, chart review study of patients with TED at a tertiary center using the Strengthening the Reporting of Observational Studies in Epidemiology checklist. The main outcome measure for severity was the European Group on Graves' Orbitopathy 2016 Severity Scale.</p><p><strong>Results: </strong>Of the 2905 charts reviewed, 99 met the inclusion criteria. The mean age was 51 (standard deviation 16) years with 78% women. Race was 49.4% Black, 39.1% Hispanic, 9.2% Caucasian, and 2.3% Asian. Smoking rates were 25% current smokers and 14% former smokers. Manifestations were proptosis (94% Hispanic and 91% Black), eyelid retraction (85% Hispanic and 79% Black), extraocular muscle (EOM) restriction (79% Hispanic and 63% Black), eyelid edema (41% Hispanic and 30% Black), chemosis (24% Hispanic and 14% Black), and optic neuropathy (18% Hispanic and 9% Black). Overall, disease severity was 22% mild, 65% moderate to severe, and 13% sight-threatening. Older patients had increased rates of optic neuropathy (<i>P</i> = 0.04). Younger patients had increased rates of proptosis (<i>P</i> = 0.02). Socioeconomic status was not associated with disease severity (<i>P</i> = 0.67).</p><p><strong>Conclusion: </strong>Hispanic and Black patients with TED presented with higher than previously established rates of proptosis, EOM restriction, and optic neuropathy. Including research of different races broadens understanding of presentation and management, improving patient outcomes.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"29 4","pages":"171-180"},"PeriodicalIF":0.5000,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754111/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Middle East African Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/meajo.meajo_87_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Knowledge of thyroid eye disease (TED) is based on predominantly Caucasian populations. To date, no studies in the United States examine the presentation in Black and Hispanic patients. The purpose of this study is to introduce the presentation of TED in two previously undescribed populations.

Methods: This is a retrospective, cross-sectional, chart review study of patients with TED at a tertiary center using the Strengthening the Reporting of Observational Studies in Epidemiology checklist. The main outcome measure for severity was the European Group on Graves' Orbitopathy 2016 Severity Scale.

Results: Of the 2905 charts reviewed, 99 met the inclusion criteria. The mean age was 51 (standard deviation 16) years with 78% women. Race was 49.4% Black, 39.1% Hispanic, 9.2% Caucasian, and 2.3% Asian. Smoking rates were 25% current smokers and 14% former smokers. Manifestations were proptosis (94% Hispanic and 91% Black), eyelid retraction (85% Hispanic and 79% Black), extraocular muscle (EOM) restriction (79% Hispanic and 63% Black), eyelid edema (41% Hispanic and 30% Black), chemosis (24% Hispanic and 14% Black), and optic neuropathy (18% Hispanic and 9% Black). Overall, disease severity was 22% mild, 65% moderate to severe, and 13% sight-threatening. Older patients had increased rates of optic neuropathy (P = 0.04). Younger patients had increased rates of proptosis (P = 0.02). Socioeconomic status was not associated with disease severity (P = 0.67).

Conclusion: Hispanic and Black patients with TED presented with higher than previously established rates of proptosis, EOM restriction, and optic neuropathy. Including research of different races broadens understanding of presentation and management, improving patient outcomes.

扩大对甲状腺眼病表现的了解,将西班牙裔和黑人患者纳入其中。
目的:人们对甲状腺眼病(TED)的了解主要基于白种人。迄今为止,美国还没有研究对黑人和西班牙裔患者的表现进行调查。本研究的目的是介绍两种以前未曾描述过的人群的 TED 表现:这是一项回顾性、横断面、病历回顾性研究,研究对象是一家三级医疗中心的 TED 患者,采用的是流行病学观察性研究加强报告核对表。衡量严重程度的主要结果是欧洲巴塞杜氏眼病小组2016年严重程度量表:在审查的2905份病历中,99份符合纳入标准。平均年龄为51岁(标准差为16岁),78%为女性。黑人占 49.4%,西班牙裔占 39.1%,白种人占 9.2%,亚裔占 2.3%。吸烟率为 25% 的现吸烟者和 14% 的前吸烟者。表现为眼球突出(94% 西班牙裔和 91% 黑人)、眼睑后缩(85% 西班牙裔和 79% 黑人)、眼外肌(EOM)受限(79% 西班牙裔和 63% 黑人)、眼睑水肿(41% 西班牙裔和 30% 黑人)、化脓(24% 西班牙裔和 14% 黑人)和视神经病变(18% 西班牙裔和 9% 黑人)。总体而言,病情严重程度为轻度的占 22%,中度至重度的占 65%,危及视力的占 13%。年龄较大的患者发生视神经病变的比例较高(P = 0.04)。年轻患者发生突眼的比例增加(P = 0.02)。社会经济地位与疾病严重程度无关(P = 0.67):结论:西班牙裔和黑人 TED 患者的突眼、EOM 受限和视神经病变发生率高于既往研究结果。将不同种族的研究纳入其中可拓宽对疾病表现和管理的理解,从而改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
1
期刊介绍: The Middle East African Journal of Ophthalmology (MEAJO), published four times per year in print and online, is an official journal of the Middle East African Council of Ophthalmology (MEACO). It is an international, peer-reviewed journal whose mission includes publication of original research of interest to ophthalmologists in the Middle East and Africa, and to provide readers with high quality educational review articles from world-renown experts. MEAJO, previously known as Middle East Journal of Ophthalmology (MEJO) was founded by Dr Akef El Maghraby in 1993.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信